Skip to content

Investigating the effect of probiotics in septicemia

the effect of probiotics in the prevention of septicemia in preterm infants

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240213060996N1
Enrollment
32
Registered
2024-04-02
Start date
2024-04-20
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Neonatal septicemia. Condition 2: Neonatal premature. Bacterial sepsis of newborn, unspecified Preterm [premature] newborn [other]

Interventions

Intervention 1: Intervention group: Probiotic recipient that receive five drops of pedilact donated to the hospital by Danesh bonian zist takhmir Company (including Lactobacillus reuteri, Lactobacillu

Sponsors

Qazvin University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Days to 28 Days

Inclusion criteria

Inclusion criteria: All infants who are less than 37 weeks old and weigh less than 2500 grams

Exclusion criteria

Exclusion criteria: infants under 32 weeks and over 37 weeks infants who have sepsis due to maternal infection such as PROM and maternal urinary infection infants who are placed under a ventilator Parents' unwillingness to participate in the study

Design outcomes

Primary

MeasureTime frame
Neonatal septicemia. Timepoint: Measurement of CBC, CRP, vital signs, urine culture, duration of hospitalization, duration of full nutrition, blood culture and weight during hospitalization and at the time of discharge. Method of measurement: Blood test, monitoring device, thermometer, urine test, scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmirreza Pourfarej

Qazvin University of Medical Sciences

arpourfaraj@gmail.com+98 28 3333 6001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026